Trevi Therapeutics Inc (TRVI)
2.865
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
2.865
0.00 (0.00%)
After-Hours: 16:43
Trevi Therapeutics Shareholders Equity (Quarterly): 58.97M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 58.97M |
| June 30, 2024 | 66.17M |
| March 31, 2024 | 72.33M |
| December 31, 2023 | 82.55M |
| September 30, 2023 | 89.61M |
| June 30, 2023 | 95.07M |
| March 31, 2023 | 101.73M |
| December 31, 2022 | 107.46M |
| September 30, 2022 | 109.90M |
| June 30, 2022 | 60.52M |
| March 31, 2022 | 10.46M |
| December 31, 2021 | 17.08M |
| Date | Value |
|---|---|
| September 30, 2021 | 11.38M |
| June 30, 2021 | 17.74M |
| March 31, 2021 | 23.68M |
| December 31, 2020 | 27.28M |
| September 30, 2020 | 35.62M |
| June 30, 2020 | 40.04M |
| March 31, 2020 | 46.80M |
| December 31, 2019 | 54.54M |
| September 30, 2019 | 60.71M |
| June 30, 2019 | 67.70M |
| March 31, 2019 | 12.68M |
| December 31, 2018 | 6.248M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.46M
Minimum
Mar 2022
109.90M
Maximum
Sep 2022
56.45M
Average
56.76M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 68.91M |
| Total Liabilities (Quarterly) | 9.939M |